Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Total return indices show comprehensive performance by including dividends. Understanding them helps investors assess risk and compare strategies effectively.
27,899 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Oil markets face geopolitical headwinds and growing demand, keeping prices above the $90 threshold. This article iden...
Hycroft Mining stock dropped 18% this week as gold and silver prices slid and investors weighed development risk. Thi...
Berkshire Hathaway sits on a massive stock portfolio and a mountain of cash. As leadership quietly shifts, investors ...
Karman Space & Defense reported a solid quarter, but its stock slipped. This article breaks down the factors behind t...
Four pure-play quantum stocks slid 6%–9% in a coordinated downturn, signaling a sector-wide rotation amid broader mar...
Investors weigh Pfizer's CFO transition as the broader market climbs. This look at the stock market today, june revea...
Ether.fi undertakes a major shift, moving its crypto card rails to OP Mainnet from Scroll, migrating tens of thousand...
A Chinese open-weights AI model stirred markets and sent Nvidia shares lower. This piece explains why the dip could a...
Big Tech is hiring high-salary communications leaders who don’t code, aiming to reduce risk and boost clarity amid ra...
A nationwide, specialized model for wealth management is gaining momentum among high-net-worth clients, offering acce...
As summer heat climbs, the strait hormuz still closed reshapes energy markets and portfolios. This guide translates r...